Ossio Inc., a Woburn, MA based developer of orthopedic fixation technology, has secured a $50 million senior credit facility led by Horizon Technology Finance Corporation, and Monroe Capital LLC.
The financing includes an initial $40 million provided at closing, with an additional $10 million available to support future growth milestones.
Read More:Nucleus Security Raises $20M in Series C Funding
The company plans to use the funds to speed up global expansion, grow its commercial operations, and expand access to its metal-free bone regeneration solutions.
OSSIO is an orthopedic company focused on improving surgical outcomes for patients, physicians, providers, and payors. The company aims to replace traditional metal implants in the global orthopedic fixation market with its OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO develops and manufactures its products in Caesarea, Israel, and runs commercial operations from Palmetto, Florida.
“Monroe continues to see strong innovation from Israel’s life sciences sector, and OSSIO is a leader in orthopedic and regenerative technology,” said Mark Solovy, Managing Director and Co-Head of the Technology Finance Group at Monroe Capital. “Its metal-free bone regeneration solutions fit well with our technology focus, and we are proud to support Brian and his team as they expand OSSIO’s global reach.”
“We are pleased to partner with Brian and the OSSIO team as they expand their global reach in orthopedic medical technology,” said Paul Seitz, Chief Investment Officer of Horizon. “This investment shows Horizon’s commitment to supporting innovative, high-growth companies through strategic financing and adds to our investments in the Israeli technology sector.”
“We are excited to partner with Horizon Technology Finance and Monroe Capital for this growth investment,” said Brian Verrier, CEO of OSSIO. “This partnership brings strong healthcare technology expertise and funding to support our global expansion. It will help us grow while staying focused on improving orthopedic care for patients.”
About Ossio
Founded in 2014 by CEO Brian Verrier, OSSIO develops OSSIOfiber Intelligent Bone Regeneration Technology, which replaces metal implants with materials that naturally turn into bone over time. The company conducts research, development, and manufacturing in Caesarea, Israel, and runs commercial operations from Palmetto, Florida.
About Horizon Technology Finance
Horizon Technology Finance Corporation, managed by Horizon Technology Finance Management LLC (an affiliate of Monroe Capital), is a specialty finance company that provides secured loans to venture-backed, private equity-backed, and public companies in technology, life sciences, healthcare, and sustainability. Horizon aims to generate strong returns through income from debt investments and potential gains from investment warrants. The company is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California and investment professionals across the U.S. Monroe Capital is a leading asset management firm focused on private credit markets, offering strategies such as direct lending, technology finance, venture debt, structured credit, real estate, and equity investments.
About Monroe Capital
Monroe Capital LLC is a leading asset management firm focused on private credit markets, offering strategies such as direct lending, technology finance, venture debt, structured credit real estate and equity. Since 2004, the firm has provided capital solutions across the U.S. and Canada partnering closely with business owners, management teams, and sponsors. Headquartered in Chicago with 12 global offices, Monroe serves institutional and high net worth investors with investment products designed to deliver strong returns across market cycles. The firm has received multiple industry awards, recognizing its performance, innovation and leadership in private credit.
Read More:Scala Raises $8.5M in Funding
